Published by Michele Maatouk on 15th December 2021
(Sharecast News) - Aim-listed Avacta said on Wednesday that its AffiDX® antigen lateral flow test has been shown to detect the Omicron variant of the SARS-CoV-2 virus in clinical samples.
URL: http://www.digitallook.com/dl/news/story/32334952/...